{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22999323",
  "DateCompleted": {
    "Year": "2013",
    "Month": "05",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2012",
        "Month": "09",
        "Day": "20"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jelectrocard.2012.08.004",
      "S0022-0736(12)00305-6"
    ],
    "Journal": {
      "ISSN": "1532-8430",
      "JournalIssue": {
        "Volume": "45",
        "Issue": "6",
        "PubDate": {
          "Year": "2012",
          "Season": "Nov-Dec"
        }
      },
      "Title": "Journal of electrocardiology",
      "ISOAbbreviation": "J Electrocardiol"
    },
    "ArticleTitle": "Selection of high-risk patients for device intervention with the new advances in technology.",
    "Pagination": {
      "StartPage": "670",
      "EndPage": "672",
      "MedlinePgn": "670-2"
    },
    "Abstract": {
      "AbstractText": [
        "The recent clinical therapeutic studies involving high-risk cardiac patients with genetic or acquired heart disease provide valuable insights into the potential for new advances in the technology for improving risk stratification to identify patients who can benefit from device therapy."
      ],
      "CopyrightInformation": "Copyright \u00a9 2012 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642-0653, USA. heartajm@heart.rochester.edu"
          }
        ],
        "LastName": "Moss",
        "ForeName": "Arthur J",
        "Initials": "AJ"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 HL033843",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Electrocardiol",
    "NlmUniqueID": "0153605",
    "ISSNLinking": "0022-0736"
  },
  "CommentsCorrectionsList": [
    {
      "RefSource": "J Electrocardiol. 2013 Mar-Apr;46(2):156-7",
      "PMID": "23312074"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Cardiac Resynchronization Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Evidence-Based Medicine"
    },
    {
      "QualifierName": [
        "epidemiology",
        "genetics"
      ],
      "DescriptorName": "Genetic Predisposition to Disease"
    },
    {
      "QualifierName": [
        "epidemiology",
        "genetics",
        "prevention & control"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Patient Selection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prevalence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Assessment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}